139 results
Page 2 of 7
8-K
e6u1lkcdjsm41gz0wh3b
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
m6onnj3rg1 721
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
EX-99.2
ookk4gv02 koz9w
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
EX-99.1
c09w47b4
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
S-3ASR
q4ofg
9 Nov 21
Automatic shelf registration
5:05pm
DEFA14A
lwyqhr3jq redvv
29 Sep 21
Additional proxy soliciting materials
12:27pm
8-K
EX-99.2
dlh dueruabs7oh9jgw9
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.1
1x5nzx7qdxm8x l0wv
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-10.1
zxrwpe1ntsag73do113b
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-10.5
7b5z31yw0b4x6b6td
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.4
mm79zgvzmca3i5
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.1
9y4v98y0
5 Aug 21
Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates
7:02am
8-K
EX-99.1
r9krh2
14 Jun 21
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors
7:27am
8-K
EX-99.1
2f2pn rutrmc
8 Jun 21
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
7:00am
8-K
89o2 9fe1lrprbmo9ao
8 Jun 21
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
7:00am